Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Addex Therapeutics

Addex Therapeutics
2002 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
ADXN STOCK SYMBOL
$2.20 SHARE PRICE (As of Friday Closing)
Description

Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SWX
Primary Office
  • 12, chemin des Aulx
  • Case postale 68, Plan-les-Ouates
  • 1228 Geneva
  • Switzerland

+41 022 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Addex Therapeutics’s full profile, request a free trial.

Addex Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.46 - $2.39 $58.2M $1.92 -$0.48 23.4K 26.5M

Addex Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 107 16,595 27,254 18,259
Revenue 2,443 6,176 0 0
EBITDA (11,215) (1,453) (3,270) (3,150)
Net Income (11,600) (1,681) (3,332) (3,196)
Total Assets 38,869 42,877 3,145 1,652
Total Debt 405 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Addex Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Addex Therapeutics‘s full profile, request access.

Request full access to PitchBook

Addex Therapeutics Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spero Therapeutics Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Geneva, Switzerland 0000 000.00 000000000000 000.00
0000000 Venture Capital-Backed Framingham, MA 0 0000 0000000000 0 0000
000000 00000000000 Corporation PA 000 000.00 0000000000 000.00
00000000 000000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Addex Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Addex Therapeutics‘s full profile, request access.

Request full access to PitchBook

Addex Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Tim Dyer Co-Founder, Board Member and Chief Executive Officer
Roger Mills MD Chief Medical Officer

5 Former Executives

You’re viewing 2 of 7 executives. Get the full list »

Addex Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Hoyoung Huh Ph.D Self Board Member 000 0000
Raymond Hill Ph.D Self Board Member 000 0000
Tim Dyer Addex Therapeutics Co-Founder, Board Member and Chief Executive Officer 000 0000
Vincent Lawton Ph.D Addex Therapeutics Chairman 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »